Interesting Endo: Pancreatic Cancer & Thyroid Function
Our October list includes potential pancreatic cancer treatments, hypothyroidism risks, and cost burdens of endocrine-disrupting chemicals.
We present a selection of interesting endocrinology articles for the month of October in the following slides. See the slide legends for links to the article summaries.
Interesting Endorinology: Pancreatic Cancer & Thyroid Function. October 2016
Sitagliptin and Risk of Fractures in Type 2 Diabetes: Results from the TECOS Trial. Abstract link.****Heavy Cannabis Use Is Associated with Low Bone Mineral Density and an Increased Risk of Fractures. Abstract link.
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. Abstract link.****Randomised, Open-Label, Phase II Study of Gemcitabine with and without IMM-101 for Advanced Pancreatic Cancer. Abstract link.
Highly Aligned Stromal Collagen Is a Negative Prognostic Factor Following Pancreatic Ductal Adenocarcinoma Resection. Abstract link.****Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. Abstract Link.
Exposure to Endocrine-Disrupting Chemicals in the USA: a Population-Based Disease Burden and Cost Analysis. Abstract Link. ****Obesogens and Male Fertility. Abstract link.
Effects of Resveratrol on Polycystic Ovary Syndrome: a Double-blind, Randomized, Placebo-controlled Trial. Abstract link.****FDA Approves New Changes to Testosterone Labeling Regarding the Risks Associated with Abuse and Dependence of Testosterone and Other Anabolic Androgenic Steroids (AAS). FDA release.
Phototherapy and Risk of Type 1 Diabetes. Abstract link. **** Autoimmune Diseases in Children and Adults with Type 1 Diabetes from the T1D Exchange Clinic Registry. Abstract link.
Clinical Outcomes of Patients with Hypothyroidism Undergoing Percutaneous Coronary Intervention. Abstract link. ****Thyroid Function and Sudden Cardiac Death. A Prospective Population-Based Cohort Study. Abstract link.
Headache Disorders May Be a Risk Factor for the Development of New Onset Hypothyroidism. Abstract Link. ****Papillary Thyroid Microcarcinoma: Time to Shift from Surgery to Active Surveillance? Abstract link.
